||EPS - Basic
||Market Cap (m)
|Real Estate Investment & Services
Real-Time news about Carecapital (London Stock Exchange): 0 recent articles
|27howard: Do not give up, this went from under 1p to over 4p in a couple of days, the market cap is tiny, you know the score, when it starts to move everybody will pile in and the spike will happen, still hopeful of at least 3 times the current price, still
think long term it could be worth double figures, one decent disposal could start
the share price motoring upwards.|
|fenseal3: If topinfo has sold thats up to him....when i first bought here my long term price was 5p-6p and then when we had all that good news and the share price dropped i sold at a small loss, i have bought back in and with the two holding RNS i'm happy to stay for a while....GLA!!|
|goodboke: From the results the share is trading at 30% of its net asset value (as i write) which is ridiculous in my view and then there is the 28.75% shareholding in Advanced Proton solutions which could add significant value to the share price in the future!|
|ydderf: i doubt if the day to day share price noise is relevant to anyone who is an investor - the heavy volume on the day of the AGM and Trading update when 27m shares were traded (equal to around 35% of the issued shares)and volume since, suggests that a significant number of those shares are being retained for now, meanwhile I doubt if anyone can do other than guess where the continuing and new activites will lead the company over the next months and years.....the published metrics and agm statement (which coincided with the very large traded volume day) are all there is to go on for now|
|crosswire: Speaking of share prices, CareCapital (LON:CARE) was the top performer in London market in morning trade.
The real estate investors with a focus on healthcare saw its share price nearly triple in early deals after saying that its 29.75 percent stake in Advanced Proton Solutions has the potential to "be of significant value".
According to the group, as a result of its involvement in APS, it has been approached by a number of providers of cancer treatments and said its operations in this field could form the basis of a new healthcare division within the group.
In November last year, the group sold its German portfolio for 27.35 million, allowing it to investment in its UK healthcare development pipeline.
The group currently has developments worth a total £21.8 million, of which £14.6 million has been forward sold to investors. Today, the group said it expects to completed these developments within the next two years.
In early afternoon, shares in the company traded at 3.88 pence, up 158 percent from yesterday's close.
CareCapital now has a market cap of nearly £3 million.
|scburbs: dkpetti, I purchased at between 4-4.5p and sold half at between 8.5-9p, so I still have half my holding.
My comments on it going north of 20p were based on the assumption that Proton Therapy Global is successful. This looks a hugely promising development, but it remains speculative until the funding entity is launched. If the funding is successful then it should do wonders for the share price. In an ideal world this fundraising would complete, then CARE would rerate upwards and then do its own equityraising. In the real world it might take the Proton Therapy fundraising a long time to complete such that CARE's equity raising or sale of German properties can not wait.
"The Company is in the process of launching a funding entity, Proton Therapy Global, Inc. that aims to raise several hundred million dollars for investment in individual proton centers."|
|dkpetti: scburbs. Thanks for your reply and opinions -I thought I was talking to myself for a while. The results seem a bit like "good news and bad news". The concerning part seems to be the independent auditors report. Do you still think the share price can go north of 20p? And do you hold these?|
|scburbs: I like the style of Trevor Brown and Free Association Books they don't mess around, although how they have managed to get 18+% of the company without the share price rocketing is a bit unclear!
I was looking forward to the trading update when I saw the header on the other RNS, unfortunately it is not really a trading update.
"CareCapital plc (AIM: CARE), the healthcare real estate developer and owner, is pleased to announce the completion of contract and funding arrangements for the development of a new Community Centre, with a total floor area of 2,555 square meters, located in Allesley Park, Coventry. The Centre will comprise a public library of 405 square meters, a medical centre of 844 square meters, a pharmacy of 154 square meters and community/medical services areas of 779 square meters. Construction is expected to commence in early July 2010 with completion in August 2011. Total expected development cost for the entire project will be £4.5 million.
The library is being funded by Coventry City Council and the medical centre and pharmacy by Primary Health Properties PLC (under a pre-sale framework agreement announced on 8 February 2010). The Company will fund, and retain for letting, the community/medical services areas for £ 600,000 from its existing financial resources. CareCapital will act as developer for the whole project and will provide facilities management for the completed building."
For me CARE is reasonably well positioned. It was certainly a gambling chip prior to the large disposal to PHP and I wasn't a holder. However, following that disposal I picked some up in the 4-4.5p range.
Medical centres are very popular at the moment as can be seen from the share price ratings afforded to PHP and MedicX. They also represent one of the most liquid property classes due to their long term government backed leases and increasing rents (very popular for pension funds as akin to a gilt, but with a higher return). This liquidity reduces the development risk for CARE along with the fact that PHP are potentially going to take more of the development pipeline. Without the disposal it was difficult to see how CARE were going to get the financing to build out the pipeline. This was illustrated by the loan from Sinclair.
They do have one risky asset which is the unlet Folkestone dental property and it would be useful to know what they are going to do with that and how much compensation they got from the proposed tenant not taking up their lease.
The next results won't cover the disposal or the completion of the German development so not ideal. Hopefully a proforma post disposal/completion will be included to give an understand of the current state of play.
With NAV in the region of 18p it looks very good value to me at under 5p given the discount and the development pipeline although running costs are a bit too high for my liking. The Sinclair shareholding is large but still less than 30% and the Sinclair loan has now been repaid reducing the risk. Undoubtably high risk, but the chances of multi-bagging are also good, particularly with the German real estate market having significantly improved in the last 6 months.
My property portfolio is a mixture of safeish high yielders like PSPI, medium risk undervalued QED/AGR and high risk massively undervalued like CARE, SDIC and quite a few others. As you would expect the first two categories are the largest holdings and the high risk category has the most investments to spread the risk. If I was only allowed one investment it would have to be PSPI due to the combination of discount and high yield.
The UK property market has recovered significantly and is unlikely to rise much from here other than increases driven by rental increases (which makes index linked leases like PSPI's and the rental growth in medical properties better investments) or developments. The European market is currently recovering and starting to rise so there may be further re-rating in some of the European shares like KEIF/IERE etc. as they start to report NAV increases.|
|moneye: I bought these after seeing Kenny comment on another board after quickly looking at figures.
I am not an accountant and do not even have massive amounts to invest but that makes it more important to try to select shares that have large potential to move up.
I have tried to look closer at the numbers, in particular the interim results that were released in Sept 2009
This statement to me still appears confident, and shows a NAV of 18.5p per share.
The Chairmans statement also referred to a valuation of the development pipeline of between 10.4 and 14.4p additional NAV per share. It stated that the outcome from that valuation was not incorporated into the half year results and that development projects were expexted to proceed.
The above would indicate a likely NAV of around 30p per share compared to a share price of 2.62p.
A massive discount which must surely indicate that this share is very oversold and give hope for an equally significant correction which could now be about to start.
This is what gives me confidence to stay with this share.
This is purely my interpretation and view and not intended as advice etc. and given my limited financial knowledge I would appreciate any feedback on my interpretation.
Kenny, I did also look on the website which gives a good overview of the company but it looks as if no major updates that would add to the above have been updated since September. It would be nice to see the share price back to the 8p level of a few months back when you last got involved|
Carecapital share price data is direct from the London Stock Exchange